OBM Transplantation

(ISSN 2577-5820)

OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 

Indexing: DOAJ-Directory of Open Access Journals.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.7 weeks (median values) after submission.

Current Issue: 2020  Archive: 2019 2018 2017

Special Issue

Bone Marrow Transplantation

Submission Deadline: October 30, 2020 (Open) Submit Now

Guest Editor

Gerhard Hildebrandt, MD, FACP

Professor of Medicine, Division Chief, Hematology & Blood and Marrow Transplantation, Adjunct Professor, Department of Microbiology, Immunology and Molecular Genetics, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC404, Lexington, KY 40536-0093, USA

Website | E-Mail

Research Interests: Hematology and blood marrow transplantation; blood cancer; amyloidosis; chronic lymphocytic leukemia (CLL); myelodyplastic syndrome; hematopoietic stem cell transplantation; graft versus host disease

Newsletter

TOP